AU713580B2 - Anthelmintic macrocyclic lactone compositions - Google Patents

Anthelmintic macrocyclic lactone compositions Download PDF

Info

Publication number
AU713580B2
AU713580B2 AU71002/96A AU7100296A AU713580B2 AU 713580 B2 AU713580 B2 AU 713580B2 AU 71002/96 A AU71002/96 A AU 71002/96A AU 7100296 A AU7100296 A AU 7100296A AU 713580 B2 AU713580 B2 AU 713580B2
Authority
AU
Australia
Prior art keywords
group
veterinary composition
composition
chosen
liquid veterinary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU71002/96A
Other languages
English (en)
Other versions
AU7100296A (en
Inventor
Colin Manson Harvey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merial Ltd
Original Assignee
Ashmont Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NZ280085A external-priority patent/NZ280085A/en
Application filed by Ashmont Holdings Ltd filed Critical Ashmont Holdings Ltd
Publication of AU7100296A publication Critical patent/AU7100296A/en
Application granted granted Critical
Publication of AU713580B2 publication Critical patent/AU713580B2/en
Assigned to MERIAL LTD reassignment MERIAL LTD Alteration of Name(s) in Register under S187 Assignors: ASHMONT HOLDINGS LIMITED
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU71002/96A 1995-09-25 1996-09-19 Anthelmintic macrocyclic lactone compositions Expired AU713580B2 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
NZ280085 1995-09-25
NZ280085A NZ280085A (en) 1995-09-25 1995-09-25 Liquid macrocyclic lactone medicament; veterinary composition also containing a vegetable oil and an alcohol having 4 or more carbon atoms
NZ28013495 1995-09-29
NZ280134 1996-07-26
NZ28013496 1996-07-26
PCT/NZ1996/000099 WO1997011709A1 (en) 1995-09-25 1996-09-19 Anthelmintic macrocyclic lactone compositions

Publications (2)

Publication Number Publication Date
AU7100296A AU7100296A (en) 1997-04-17
AU713580B2 true AU713580B2 (en) 1999-12-02

Family

ID=27353760

Family Applications (1)

Application Number Title Priority Date Filing Date
AU71002/96A Expired AU713580B2 (en) 1995-09-25 1996-09-19 Anthelmintic macrocyclic lactone compositions

Country Status (7)

Country Link
US (1) US6013636A (ko)
EP (1) EP0873127B1 (ko)
KR (1) KR100277287B1 (ko)
AU (1) AU713580B2 (ko)
CA (1) CA2233016C (ko)
DE (1) DE69636706T2 (ko)
WO (1) WO1997011709A1 (ko)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ335166A (en) * 1999-04-14 2001-11-30 Ashmont Holdings Ltd Anthelmintic composition containing triclabendazole in at least one solvent
DE19638045A1 (de) * 1996-09-18 1998-03-19 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen
CA2211949A1 (en) * 1997-07-21 1999-01-29 David Farley Johnson Nonaqueous compositions for parenteral administration
DE69818093T2 (de) * 1997-12-03 2004-06-09 Merck & Co., Inc. Langwirkende, injizierbare, formulierungen enthaltend rizinusöl
US6174540B1 (en) 1998-09-14 2001-01-16 Merck & Co., Inc. Long acting injectable formulations containing hydrogenated caster oil
KR20000025762A (ko) * 1998-10-14 2000-05-06 유충식 이버멕틴류의 가용화 조성물
GB9827727D0 (en) 1998-12-16 1999-02-10 Pfizer Ltd Antiparasitic formulations
AU781682B2 (en) * 2000-03-20 2005-06-09 Zoetis Services Llc Sustained-release compositions for parenteral administration
US7897559B2 (en) * 2000-06-29 2011-03-01 Parks L Dean Dermatological composition and kit containing avermectin compound for treating dermatological conditions
US20050009762A1 (en) * 2003-06-06 2005-01-13 Strobel Michael Albert Application of water and organic solvent soluble ivermectin for topical and oral use
US6627613B2 (en) 2001-07-23 2003-09-30 Michael A. Strobel Application of water and organic solvent soluble ivermectin for topical and oral use
US7064108B2 (en) * 2002-02-08 2006-06-20 Merck & Co., Inc. Topical ivermectin composition
KR100600406B1 (ko) * 2002-07-22 2006-07-14 주식회사 엘지생명과학 주사용 이버멕틴 조성물 및 그 제조방법
US7368435B2 (en) * 2002-09-12 2008-05-06 Summit Vetpharm, Llc Topical endoparasiticide and ectoparasiticide formulations
US20050245582A1 (en) * 2002-09-12 2005-11-03 The Hartz Mountain Corporation High concentration topical insecticides containing pyrethroids
FR2854074B1 (fr) 2003-04-24 2007-11-23 Galderma Res & Dev Utilisation de l'ivermectine pour le traitement de desordres dermatologiques
WO2006039079A2 (en) * 2004-09-08 2006-04-13 Summit Vetpharm, Llc Topical endoparasiticide and ectoparasiticide formulations
FR2900052B1 (fr) * 2006-04-19 2011-02-18 Galderma Sa Composition comprenant au moins une phase aqueuse et au moins une phase grasse comprenant de l'ivermectine
FR2906467B1 (fr) * 2006-09-28 2012-11-09 Galderma Sa Utilisation de composes de la famille des milbemycines pour le traitement de desordres dermatologiques chez l'homme
BRPI0705822A2 (pt) * 2007-10-25 2009-06-23 Schering Plough Saude Animal Ltda formulação injetável com ação prolongada e uso de um agente semi-sintético derivado do grupo das avermectinas, em combinação com um polìmero biodegradável
US20100022469A1 (en) * 2008-06-24 2010-01-28 Majid Razzak Anthelminthic formulations
CN102316876B (zh) 2009-02-16 2013-07-17 佐蒂斯有限责任公司 高剂量多拉菌素制剂
BR112012008185A2 (pt) * 2009-10-07 2016-08-16 Wyeth Llc composições que compreendem adjuvante, macrolídeo e antígeno proteináceo, e métodos para uso dessas composições
RU2578036C2 (ru) 2010-06-29 2016-03-20 Сева Санте Анимале Са Новые инъекционные композиции эприномектина
NZ594610A (en) * 2011-08-16 2013-03-28 Virbac New Zealand Ltd Injectable Anthelmintic Formulations cotaining levamisole and one or more macrocyclic lactones for controlling internal parasites in ruminants
WO2013137748A1 (en) 2012-03-13 2013-09-19 Bayer New Zealand Limited Long acting compositions
US11638714B2 (en) 2020-11-10 2023-05-02 Mountain Valley Md Inc Water dissolvable macrocyclic lactone cyclodextrin complexes
US11077134B1 (en) 2020-11-10 2021-08-03 Mountain Valley Md Inc Water dissolvable macrocyclic lactone cyclodextrin complexes
WO2022144575A1 (es) * 2020-12-30 2022-07-07 Procaps S.A. Formulación de ivermectina en solución oral

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1207683A (en) * 1982-03-16 1983-09-22 Wellcome Australia Limited Pour on parisiticide of pyrethroid and thiazole
AU2750588A (en) * 1988-01-15 1989-07-20 Ancare Distributors Limited Anthelmintic compositions
WO1993003751A1 (en) * 1991-08-26 1993-03-04 Abbott Laboratories Compositions and methods for the sublingual or buccal administration of therapeutic agents

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389397A (en) * 1980-08-04 1983-06-21 Merck & Co., Inc. Solubilization of ivermectin in water
US4784845A (en) * 1985-09-16 1988-11-15 American Cyanamid Company Emulsion compostions for the parenteral administration of sparingly water soluble ionizable hydrophobic drugs
JPH0816066B2 (ja) * 1986-07-18 1996-02-21 エーザイ株式会社 持続性薬効製剤
DE3727648A1 (de) * 1987-08-19 1989-03-02 Bayer Ag Neue avermectin derivate, verfahren zu ihrer herstellung und ihre verwendung
JPH0570366A (ja) * 1991-03-08 1993-03-23 Meiji Seika Kaisha Ltd 薬用組成物
NZ248486A (en) * 1993-08-24 1996-07-26 Ashmont Holdings Limited Subst Stable anthelmintic formulation containing closantel and one or more avermectins or milbemycins in a glycol based solvent
NZ250188A (en) * 1993-11-11 1996-06-25 Ashmont Holdings Ltd Substitut Anthelmintic drench comprising an avermectin or milbemycin and an organic selenium salt
US5674897A (en) * 1995-10-20 1997-10-07 Mycogen Corporation Materials and methods for controlling nematodes
US5773422A (en) * 1996-01-29 1998-06-30 Komer; Gene Avermectin formulation
AUPN933396A0 (en) * 1996-04-17 1996-05-09 Pfizer Pty Limited Non-aqueuos oral-drench compositions containing avermectin compounds

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1207683A (en) * 1982-03-16 1983-09-22 Wellcome Australia Limited Pour on parisiticide of pyrethroid and thiazole
AU2750588A (en) * 1988-01-15 1989-07-20 Ancare Distributors Limited Anthelmintic compositions
WO1993003751A1 (en) * 1991-08-26 1993-03-04 Abbott Laboratories Compositions and methods for the sublingual or buccal administration of therapeutic agents

Also Published As

Publication number Publication date
KR19990063745A (ko) 1999-07-26
WO1997011709A1 (en) 1997-04-03
DE69636706D1 (de) 2006-12-28
DE69636706T2 (de) 2007-10-11
EP0873127A4 (en) 1999-06-16
EP0873127A1 (en) 1998-10-28
KR100277287B1 (ko) 2001-01-15
CA2233016C (en) 2007-07-17
EP0873127B1 (en) 2006-11-15
AU7100296A (en) 1997-04-17
US6013636A (en) 2000-01-11
CA2233016A1 (en) 1997-04-03

Similar Documents

Publication Publication Date Title
AU713580B2 (en) Anthelmintic macrocyclic lactone compositions
Shoop et al. Eprinomectin: a novel avermectin for use as a topical endectocide for cattle
West Black's veterinary dictionary
EP1136081B1 (en) Sustained-release compositions for the parenteral administration of macrolides
Hamel et al. Treatment and control of bovine sarcoptic and psoroptic mange infestation with ivermectin long-acting injectable (IVOMEC® GOLD)
DiPietro et al. Clinical trial of moxidectin oral gel in horses
Sulik et al. Antiparasitic activity of ivermectin: Four decades of research into a “wonder drug”
Cringoli et al. Efficacy of eprinomectin pour-on against gastrointestinal nematode infections in sheep
Cripps et al. The efficacy of anthelmintic drugs against nematodes infecting free-ranging eastern grey kangaroos, Macropus giganteus
Hooke et al. Therapeutic and protective efficacy of doramectin injectable against gastrointestinal nematodes in cattle in New Zealand: A comparison with moxidectin and invermectin pour-on formulations
AU701413B2 (en) Anthelmintic compositions
EP2744495B1 (en) Anthelmintic formulations and treatments
RU2412697C1 (ru) Способ лечения гельминтозов жвачных животных и лекарственное средство для его осуществления
deC Bronsvoort et al. Repeated high doses of avermectins cause prolonged sterilisation, but do not kill, Onchocerca ochengi adult worms in African cattle
NZ280085A (en) Liquid macrocyclic lactone medicament; veterinary composition also containing a vegetable oil and an alcohol having 4 or more carbon atoms
Monahan et al. The use of macrocyclic lactones to control parasites of horses.
AU2001235489A1 (en) Veterinary compositions for the treatment of parasitic diseases
US20120196821A1 (en) Method and formulation for the control of parasites
Hidalgo-Argüello et al. Efficacy of moxidectin 1% injectable and 0.2% oral drench against natural infection by Dictyocaulus filaria in sheep
Oksanen et al. Moxidectin as an endectocide in reindeer
Holm-Martin et al. Evaluation of a single injection of a sustained-release formulation of moxidectin for prevention of experimental heartworm infection after 12 months in dogs
Watson et al. Efficacy of doramectin against experimental infections by some nematode parasites in cattle in New Zealand
Oksanen Antti Oksanen; Endectocide treatment of the reindeer
Becskei et al. Efficacy of orally administered combination of moxidectin, sarolaner and pyrantel (Simparica Trio
Panitz et al. Resistance to ivermectin and the effect of topical eprinomectin on faecal egg counts in St Croix white hair sheep

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
GD Licence registered

Name of requester: ANCARE AUSTRALIA PTY LTD.